Biotech company developing novel circular RNA-based therapies to treat currently incurable diseases
Nocturna Therapeutics has raised $712K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2023.
Nocturna Therapeutics is headquartered in Barcelona, Spain.
Biotech company developing novel circular RNA-based therapies to treat currently incurable diseases
Nocturna Therapeutics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nocturna Therapeutics — Funding & Investors." VCBacked, January 10, 2023, https://www.vcbacked.co/company/nocturna-therapeutics. Accessed August 15, 2026.
VCBacked. (2023). Nocturna Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/nocturna-therapeutics
{{cite web |title=Nocturna Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nocturna-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated